CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
University of California, San Diego |
Dr. Alon Goren |
Foundation – Discovery Stage Research Projects |
Establishment of a novel approach to systematically study the dynamic organization of protein complexes in stem cells |
$1,515,601 |
University of California, Los Angeles |
UCLA Gay M Crooks |
Foundation – Discovery Stage Research Projects |
Engineering pluripotent stem cells for universally available, off-the-shelf T cell therapies |
$1,352,753 |
University of California, San Francisco |
Yin Shen PhD |
Foundation – Discovery Stage Research Projects |
Understanding Chemotherapy-Induced Peripheral Neuropathy Mechanisms using CRISPRi and Chemical Screens in Human iPSC-Derived Sensory Neurons |
$1,621,913 |
University of California, Santa Cruz |
Dr. Camilla Forsberg |
Foundation – Discovery Stage Research Projects |
Determining how age-specific heterogeneity of human hematopoietic stem cells and megakaryocyte progenitors contribute to thrombotic disease upon aging |
$1,336,800 |
University of California, San Francisco |
Dr. Elizabeth Crouch |
Foundation – Discovery Stage Research Projects |
Harnessing vascular stem cells to grow and protect the human brain |
$1,391,998 |
Gladstone Institutes, J. David |
Julia Kaye |
Foundation – Discovery Stage Research Projects |
Developing a Human Model of Sporadic ALS Using Machine Learning and Robotic Microscopy |
$1,406,622 |
Cedars-Sinai Medical Center |
Dmitriy Sheyn |
Foundation – Discovery Stage Research Projects |
The role of WNT and BMP signaling pathways in iPSC to iTenocyte step-wise differentiation for tendon repair |
$1,516,563 |
Stanford University |
Dr. Marius Wernig MD, PhD |
Foundation – Discovery Stage Research Projects |
Developing a microglia replacement therapy |
$1,378,365 |
Greenstone Biosciences, Inc. |
Dr. Mukhtar Ahmed |
Foundation – Discovery Stage Research Projects |
Drug Discovery for Dilated Cardiomyopathy using Patient-Derived Human iPSCs |
$1,350,000 |
University of California, San Diego |
Heidi Cook-Andersen |
Foundation – Discovery Stage Research Projects |
Towards a trophectoderm stem-cell model representing human blastocysts of the highest implantation potential |
$1,584,000 |
University of California, San Diego |
Dr. Alexis Komor |
Foundation – Discovery Stage Research Projects |
Development of a stem-cell based approach to interpret global effects of genetic variants contributing to neurodevelopmental disease risk |
$1,518,982 |
University of California, Berkeley |
Dr. Michael P. Rapé Dr. |
Foundation – Discovery Stage Research Projects |
Control of OCT4 abundance and function in human stem cells |
$1,234,023 |
University of California, San Francisco |
Dr. Robert Blelloch MD, PHD. |
Foundation – Discovery Stage Research Projects |
Development of universal off-the-shelf iPSC derived dendritic cells for use as patient specific anti-tumor vaccine |
$1,391,999 |
University of California, San Francisco |
Harold A. Chapman |
Foundation – Discovery Stage Research Projects |
Modulation of human alveolar stem cells to promote lung regeneration and avoid pulmonary fibrosis |
$1,626,001 |
University of California, San Diego |
Francesca Soncin |
Foundation – Discovery Stage Research Projects |
Drivers of trophoblast stem/progenitor cell identity in human placenta |
$993,881 |
University of California, Los Angeles |
Dr Melissa Jan Spencer |
Foundation – Discovery Stage Research Projects |
Engineering AAV capsids for transduction of neural and muscle stem cells |
$999,999 |
University of California, San Francisco |
Mark C. Walters M.D. |
Cure Sickle Cell Initiative Clinical Trial Stage Projects |
Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease |
$8,389,407 |
Boston Children’s Hospital |
David Williams |
Cure Sickle Cell Initiative Clinical Trial Stage Projects |
Phase 2 Study of Hematopoietic Stem Cell Gene Transfer Inducing Fetal Hemoglobin in Sickle Cell Disease |
$8,333,581 |
University of California, Irvine |
Daniela A. Bota |
Alpha Stem Cell Clinics Network Expansion |
A hub and spoke community model to equitably deliver regenerative medicine therapies to diverse populations across four California counties |
$8,000,000 |
University of Southern California |
Thomas Buchanan |
Alpha Stem Cell Clinics Network Expansion |
Alpha Clinic Network Expansion for Cell and Gene Therapies |
$7,999,983 |
University of California, Los Angeles |
Dr. Noah Carvajal Federman |
Alpha Stem Cell Clinics Network Expansion |
Expansion of the Alpha Stem Cell and Gene Therapy Clinic at UCLA |
$8,000,000 |
University of California, San Diego |
Catriona Jamieson |
Alpha Stem Cell Clinics Network Expansion |
UC San Diego Health CIRM Alpha Stem Cell Clinic |
$8,000,000 |
University of California, Davis |
Dr Mehrdad Abedi |
Alpha Stem Cell Clinics Network Expansion |
Alpha Stem Cell Clinic for Northern and Central California |
$7,999,997 |
City of Hope, Beckman Research Institute |
Dr. Leo D Wang |
Alpha Stem Cell Clinics Network Expansion |
The City of Hope Alpha Clinic: A roadmap for equitable and inclusive access to regenerative medicine therapies for all Californians |
$8,000,000 |
Cedars-Sinai Medical Center |
Dr. Michael I Lewis |
Alpha Stem Cell Clinics Network Expansion |
A comprehensive stem cell and gene therapy clinic to advance new therapies for a diverse patient population in California |
$7,957,966 |
University of California, San Francisco |
Mark C. Walters M.D. |
Alpha Stem Cell Clinics Network Expansion |
University of California, San Francisco (UCSF) Alpha Stem Cell Clinic (ASCC) |
$7,994,347 |
Stanford University |
Dr. Matthew H Porteus |
Alpha Stem Cell Clinics Network Expansion |
The Stanford Alpha Stem Cell Clinic |
$6,920,810 |
Generation STEAM |
Silvana DelPiccolo |
Conference – Manage The SPARK Annual Meeting |
Manage the 2025 Annual SPARK Conference |
$114,000 |
Children’s Hospital of Los Angeles |
Dr Biraj Mahato |
Quest – Discovery Stage Research Projects |
Chemically engineered photoreceptors for vision restoration in retinal degeneration associated blindness. |
$1,711,000 |
University of California, Irvine |
Dr. Aileen J Anderson |
Quest – Discovery Stage Research Projects |
Therapeutic targeting of Glioblastoma Stem Cell survival and self-renewal signaling |
$2,250,144 |
University of California, San Francisco |
Prof. Claire Clelland |
Quest – Discovery Stage Research Projects |
Developing a universal CRISPR gene therapy approach to treat C9orf72 ALS |
$2,740,592 |
University of California, Los Angeles |
Dr. Koki Morizono |
Quest – Discovery Stage Research Projects |
B cell receptor-mediated lentiviral expression of anti-HIV antibody |
$2,751,504 |
University of California, San Diego |
Dr. Neil Carson Chi |
Quest – Discovery Stage Research Projects |
Modulating cardiac myosin heavy chain isoform expression for treating cardiomyopathies |
$2,772,000 |
City of Hope, Beckman Research Institute |
Dr. Christine E. Brown |
Quest – Discovery Stage Research Projects |
Development of a Trifunctional Self-Renewing Memory CAR T Cell Therapy to Overcome the Heterogeneity and Suppressive Microenvironment of Glioblastoma |
$2,700,810 |
University of California, San Francisco |
Faranak Fattahi |
Quest – Discovery Stage Research Projects |
Drug discovery for Charcot Marie Tooth Disease using hPSC-derived Schwann cells |
$2,471,664 |
University of California, San Francisco |
Dr. Qizhi Tang PhD |
Quest – Discovery Stage Research Projects |
Genome editing of human Tregs to enable combinational tolerogenic therapy with T cell-targeted biologics for T1D |
$2,485,549 |
Palo Alto Veterans Institute for Research |
Dr Jian Luo |
Quest – Discovery Stage Research Projects |
Human induced pluripotent stem cells-derived glial enriched progenitors for the treatment of mild traumatic brain injury |
$2,255,189 |
Palo Alto Veterans Institute for Research |
Irene Lorenzo Llorente |
Quest – Discovery Stage Research Projects |
Inhibitory interneurons derived from human induced pluripotent stem cells to treat stroke |
$2,140,122 |
University of California, San Francisco |
Faranak Fattahi |
Quest – Discovery Stage Research Projects |
Drug discovery for gastrointestinal motility disorders using hPSC-derived enteric ganglioids |
$1,954,367 |
Savanna Biotherapeutics, Inc. |
Dr. Sunil Gandhi Ph.D |
Quest – Discovery Stage Research Projects |
Gene-corrected human microglia for the treatment of adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) |
$1,417,948 |
Cedars-Sinai Medical Center |
Dr. Ritchie Ho |
Quest – Discovery Stage Research Projects |
C9orf72 repeat expansion-tuned allelic suppression by CRISPRi as an ALS therapy |
$2,274,768 |
University of Southern California |
Dr. Justin K Ichida |
Quest – Discovery Stage Research Projects |
Development of a VAV2 antisense oligonucleotide (ASO) treatment for ALS |
$2,072,560 |
University of California, Davis |
Ricardo Anibal Maselli MD |
Quest – Discovery Stage Research Projects |
Treatment of Myasthenic Syndrome due to Choline Acetyltransferase Deficiency Using AAV9-mediated Gene Therapy |
$1,500,000 |
Adverum Biotechnologies |
Cameron Keast Baker |
Quest – Discovery Stage Research Projects |
Development of an Optogenetic Vision Restoration Gene Therapy Using an Engineered Form of Melanopsin |
$1,150,820 |
University of California, San Francisco |
Michael Wilson |
Quest – Discovery Stage Research Projects |
A First-in-Class Treatment for Progressive Multifocal Leukoencephalopathy Via Multimodal Immune System Engineering |
$2,182,396 |
Stanford University |
Dr. Robert Negrin MD |
Quest – Discovery Stage Research Projects |
Orthogonal IL2 Receptor Transduced Regulatory T Cells for Clinical Application |
$1,920,652 |
Stanford University |
Dr. Michael F Clarke |
Quest – Discovery Stage Research Projects |
Developing a breast cancer stem cell drug |
$2,053,727 |
Cedars-Sinai Medical Center |
Dr. Ke Liao |
Quest – Discovery Stage Research Projects |
RNA-based therapeutics to augment regulatory T cells: a novel approach to treat myocarditis |
$2,264,509 |
University of Southern California |
Dr Linda Sher M.D. |
Quest – Discovery Stage Research Projects |
Assessing the Functional, Immunologic and Microbiologic Characteristics of Human Livers Created in Chimeric Pigs |
$2,736,590 |
University of California, Irvine |
Jianhua Yu |
Quest – Discovery Stage Research Projects |
Reprogramming Somatic Cells into iPSCs Engineered with an Anti-PSCA CAR to Develop Allogeneic Off-the-Shelf Cell Therapy to Treat Pancreatic Cancer |
$1,509,000 |